USP Methods for the Analysis of Naproxen Using Legacy L1 Column

  Application Notes: Naproxen is a common NSAID used for pain relief and fever reducer. According to the USP methods, naproxen contains no less than 98% and no more than 101.5 percent naproxen calculated on a dried basis. The USP HPLC method for the separation of naproxen was developed on Legacy L1 column according to the US Pharmacopeia methodology. L1 classification is assigned to reversed-phase HPLC column containing C18 ligand. Support for the material is spherical silica gel with particles size 3-10 um and pore size of 100-120A. Resolution between critical pairs corresponds to rules and specifications of USP. Application Columns: Legacy L1 C18 HPLC column Application compounds: naproxen and benzophenone Mobile phase: water/MeCN/Glacial Acetic acid (49/50/1) Detection technique: UV Reference: USP35: NF30  

Condition

Column Legacy L1, 4.6x150 mm, 5 µm, 100A
Mobile Phase H2O/MeCN/Glacial Acetic acid (49/50/1)
Buffer Glacial Acetic acid
Flow Rate 1.0 ml/min
Detection UV, 254 nm
 

Description

Class of Compounds Drug, Hydrophobic, Ionizable
Analyzing Compounds Naproxen, Benzophenone
 
SIELC Technologies usually develops more than one method for each compound on our website. Therefore, this particular method may not be the best available method from our portfolio for your specific application. Before you decide to implement this method in your research, please send us an email to research@sielc.com so we can ensure you get optimal results for your compound of interest.
Application Analytes:
Naproxen Sodium

Application Detection:
UV Detection